BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 22815318)

  • 1. Evaluation of children with chronic immune thrombocytopenic purpura and Evans syndrome treated with rituximab.
    Gokcebay DG; Tavil B; Fettah A; Yarali N; Azik FM; Tunc B
    Clin Appl Thromb Hemost; 2013; 19(6):663-7. PubMed ID: 22815318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term efficiency of rituximab therapy in children with chronic immune thrombocytopenic purpura.
    Gurlek Gokcebay D; Guzelkucuk Z; Yarali N
    Transfus Apher Sci; 2018 Jun; 57(3):416-417. PubMed ID: 29753699
    [No Abstract]   [Full Text] [Related]  

  • 3. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome.
    Shanafelt TD; Madueme HL; Wolf RC; Tefferi A
    Mayo Clin Proc; 2003 Nov; 78(11):1340-6. PubMed ID: 14601692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
    Ay Y; Karapinar TH; Oymak Y; Toret E; Demirag B; Ince D; Ozcan E; Moueminoglou N; Koker SA; Vergin C
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):431-5. PubMed ID: 26656905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab for children with immune thrombocytopenia: a systematic review.
    Liang Y; Zhang L; Gao J; Hu D; Ai Y
    PLoS One; 2012; 7(5):e36698. PubMed ID: 22666325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of children with refractory immune thrombocytopenia treated with rituximab.
    Matsubara K; Takahashi Y; Hayakawa A; Tanaka F; Nakadate H; Sakai M; Maeda N; Oka T; Ishii E; Bessho F; Morimoto T; Goto H; Hashii Y; Hatakeyama N; Shirahata A; Imaizumi M
    Int J Hematol; 2014 Apr; 99(4):429-36. PubMed ID: 24609717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multi-centre, single-arm, open-label study evaluating the safety and efficacy of fixed dose rituximab in patients with refractory, relapsed or chronic idiopathic thrombocytopenic purpura (R-ITP1000 study).
    Tran H; Brighton T; Grigg A; McRae S; Dixon J; Thurley D; Gandhi MK; Truman M; Marlton P; Catalano J
    Br J Haematol; 2014 Oct; 167(2):243-51. PubMed ID: 25041261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab for refractory Evans syndrome and other immune-mediated hematologic diseases.
    Mantadakis E; Danilatou V; Stiakaki E; Kalmanti M
    Am J Hematol; 2004 Nov; 77(3):303-10. PubMed ID: 15495242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia.
    Rossignol J; Michallet AS; Oberic L; Picard M; Garon A; Willekens C; Dulery R; Leleu X; Cazin B; Ysebaert L
    Leukemia; 2011 Mar; 25(3):473-8. PubMed ID: 21127498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
    Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R
    Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients.
    Peñalver FJ; Jiménez-Yuste V; Almagro M; Alvarez-Larrán A; Rodríguez L; Casado M; Gallur L; Giraldo P; Hernández R; Menor D; Rodríguez MJ; Caballero D; González R; Mayans J; Millán I; Cabrera JR;
    Ann Hematol; 2006 Jun; 85(6):400-6. PubMed ID: 16550390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adults.
    Serris A; Amoura Z; Canouï-Poitrine F; Terrier B; Hachulla E; Costedoat-Chalumeau N; Papo T; Lambotte O; Saadoun D; Hié M; Blanche P; Lioger B; Gottenberg JE; Godeau B; Michel M
    Am J Hematol; 2018 Mar; 93(3):424-429. PubMed ID: 29247540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment with the monoclonal antibody rituximab in two children with refractory autoimmune thrombocytopenia.
    Pusiol A; Cesaro S; Nocerino A; Picco G; Zanesco L; Bisogno G
    Eur J Pediatr; 2004 Jun; 163(6):305-7. PubMed ID: 15346911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolate mofetil for the treatment of children with immune thrombocytopenia and Evans syndrome. A retrospective data review from the Italian association of paediatric haematology/oncology.
    Miano M; Ramenghi U; Russo G; Rubert L; Barone A; Tucci F; Farruggia P; Petrone A; Mondino A; Lo Valvo L; Crescenzio N; Bellia F; Olivieri I; Palmisani E; Caviglia I; Dufour C; Fioredda F
    Br J Haematol; 2016 Nov; 175(3):490-495. PubMed ID: 27447678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment with rituximab of refractory idiopathic thrombocytopenic purpura in a patient with Kabuki syndrome.
    Torii Y; Yagasaki H; Tanaka H; Mizuno S; Nishio N; Muramatsu H; Hama A; Takahashi Y; Kojima S
    Int J Hematol; 2009 Sep; 90(2):174-176. PubMed ID: 19662467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful rituximab therapy in refractory autoimmune hepatitis and Evans syndrome.
    Carey EJ; Somaratne K; Rakela J
    Rev Med Chil; 2011 Nov; 139(11):1484-7. PubMed ID: 22446656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A patient with mixed type Evans syndrome: efficacy of rituximab treatment.
    Park CY; Chung CH
    J Korean Med Sci; 2006 Dec; 21(6):1115-6. PubMed ID: 17179698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenence rituximab following induction in autoimmune cytopenias.
    Rai MP; Lee EJ; Bussel JB
    Br J Haematol; 2023 Jul; 202(1):153-158. PubMed ID: 37086173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of chronic immune thrombocytopenic purpura with rituximab in children.
    Dogan M; Oner AF; Acikgoz M; Uner A
    Indian J Pediatr; 2009 Nov; 76(11):1141-4. PubMed ID: 20092026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.